Mhanna, L., Guibert, N., Milia, J., & Mazieres, J. (2019). When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer? Curr Treat Options Oncol.
Citación estilo ChicagoMhanna, Laurent, Nicolas Guibert, Julie Milia, y Julien Mazieres. "When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?" Curr Treat Options Oncol 2019.
Cita MLAMhanna, Laurent, Nicolas Guibert, Julie Milia, y Julien Mazieres. "When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?" Curr Treat Options Oncol 2019.
Precaución: Estas citas no son 100% exactas.